KILITCH DRUGS (INDIA)
Back to All Ratios
|
KILITCH DRUGS (INDIA) Last 5 Year Return on Capital Employed (ROCE) History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| ROCE(%) | 12.37 | 16.90 | 13.30 | 10.26 | 7.26 |
What is the latest Return on Capital Employed (ROCE) ratio of KILITCH DRUGS (INDIA) ?
| Year | Return on Capital Employed (ROCE) |
|---|---|
| Mar2026 | 12.37 |
| Mar2025 | 16.90 |
| Mar2024 | 13.30 |
| Mar2023 | 10.26 |
| Mar2022 | 7.26 |
How is Return on Capital Employed (ROCE) of KILITCH DRUGS (INDIA) Trending?
| Years | Return on Capital Employed (ROCE) | % Change | |
|---|---|---|---|
| Mar2026 | 12.37 | -26.80 | |
| Mar2025 | 16.9 | 27.07 | |
| Mar2024 | 13.3 | 29.63 | |
| Mar2023 | 10.26 | 41.32 | |
| Mar2022 | 7.26 | - | |
Other Financial Ratios of KILITCH DRUGS (INDIA)
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Return on Capital Employed (ROCE) ratio of peers of KILITCH DRUGS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KILITCH DRUGS (INDIA) | ₹817.3 Cr | 6% | 36.2% | 25.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,562.0 Cr | -3.2% | -7.8% | 14.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹244,572.0 Cr | -3.3% | -0.2% | 63.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹180,871.0 Cr | -2.4% | -5% | 33.6% | Stock Analytics | |
| CIPLA | ₹107,770.0 Cr | -4% | -5.6% | -10.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,829.0 Cr | -1.2% | 4.1% | -4.2% | Stock Analytics | |
KILITCH DRUGS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KILITCH DRUGS (INDIA) | 6% |
36.2% |
25.2% |
| SENSEX | -2.1% |
-5.9% |
-10.8% |
You may also like the below Video Courses